Protein microarrays labelled with fluorophores constitute a versatile platform for high-throughput analysis of protein interactions, expression levels and post-translational modifications. In a ...

Abstract: Read depth (RD) signals anomaly-based copy number variation (CNV) detection methods using whole genome sequencing data are affected by the measurement scale and parameters, and the ...

Abstract: Copy number variations (CNVs) are a type of structural variation in the genome that impact gene dosage, with significant implications for both normal phenotypic variability and ...

Most CNV detection methods are specifically developed for diploid genomes without specific consideration of effects on haploid genomes. Single-cell or low-input sequencing data generally displays ...

The phase 1/2 randomized trial compared results from the measles and rubella vaccine delivered by a microarray patch, a small sticking plaster-like device with an array of microscopic projections that ...

We need to determine whether PennCNV is appropriate and effective for analyzing data generated from low-resolution arrays (such as array-CGH with an overall median probe genomi spacing of 40-60 kb).

A deep learning approach utilizing clinical and molecular data for identifying prognostic biomarkers in patients treated with immune checkpoint inhibitors: An ORIEN pan-cancer study. This is an ASCO ...

School of Food and Biological Engineering, Jiangsu University, Zhenjiang 212013, P. R. China College of Food and Biological Engineering, Jimei University, Xiamen 361021, P. R. China Article Views are ...

The webinar will cover important aspects of the genomic analysis of inherited cancer, including guidelines, challenges, and solutions. It will focus on the importance of copy number variation (CNV) ...

Framingham genetic medicine firm Variantyx has launched a new genome-based test for chromosomal abnormalities. The IriSight CNV Analysis tests for abnormalities potentially causing pregnancy loss or ...

FRAMINGHAM, Mass.--(BUSINESS WIRE)--Variantyx, a leader in genomic precision medicine, today announced the launch of its IriSight™ CNV Analysis - a whole genome-based test for the detection of ...